Gene · 8741
Papers1,439
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 1,439
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Characterizing immune variation and diagnostic indicators of preeclampsia by single-cell RNA sequencing and machine learning. | Commun Biol | 2024 | 38182876 | PubTator, text mining | PubMed |
| Prognostic value of mitochondrial CKMT2 in Pan-cancer and its tumor immune correlation analysis. | Sci Rep | 2024 | 38172162 | PubTator, text mining | PubMed |
| Screening of novel tumor-associated antigens for lung adenocarcinoma mRNA vaccine development based on pyroptosis phenotype genes. | BMC Cancer | 2024 | 38166691 | PubTator, text mining | PubMed |
| B cell activating factor levels are linked to distinct B cell markers in multiple sclerosis and following B cell depletion and repopulation. | Clin Immunol | 2024 | 38101497 | PubTator, text mining | PubMed |
| Human gingival fibroblasts are a source of B cell-activating factor during periodontal inflammation. | J Periodontol | 2024 | 38088123 | PubTator, text mining | PubMed |
| CD4 dim CD8 bright T cells are inversely associated with neuro-inflammatory markers among people with HIV. | AIDS | 2024 | 37792358 | PubTator, text mining | PubMed |
| The role of BAFF and APRIL in IgA nephropathy: pathogenic mechanisms and targeted therapies. | Front Nephrol | 2023 | 38362118 | PubTator, text mining | PubMed |
| Endogenous retroviruses Suppressyn and Syncytin-2 as innovative prognostic biomarkers in Acute Myeloid Leukemia. | Front Cell Infect Microbiol | 2023 | 38274728 | PubTator, text mining | PubMed |
| Anticytokine Autoantibodies in Infectious Diseases: A Practical Overview. | Int J Mol Sci | 2023 | 38203686 | PubTator, text mining | PubMed |
| An Update on the Genetics of IgA Nephropathy. | J Clin Med | 2023 | 38202130 | PubTator, text mining | PubMed |
| CD24 May Serve as an Immunotherapy Target in Triple-Negative Breast Cancer by Regulating the Expression of PD-L1. | Breast Cancer (Dove Med Press) | 2023 | 38164371 | PubTator, text mining | PubMed |
| Inflammatory immune profiles associated with disease severity in pulmonary tuberculosis patients with moderate to severe clinical TB or anemia. | Front Immunol | 2023 | 38162636 | PubTator, text mining | PubMed |
| Unraveling the enigma of B cells in diffuse large B-cell lymphoma: unveiling cancer stem cell-like B cell subpopulation at single-cell resolution. | Front Immunol | 2023 | 38149239 | PubTator, text mining | PubMed |
| Transcriptomic correlates of cell cycle checkpoints with distinct prognosis, molecular characteristics, immunological regulation, and therapeutic response in colorectal adenocarcinoma. | Front Immunol | 2023 | 38143740 | PubTator, text mining | PubMed |
| Comprehensive Analysis Reveals the Potential Roles of CDKN3 in Pancancer and Verification in Endometrial Cancer. | Int J Gen Med | 2023 | 38106976 | PubTator, text mining | PubMed |
| Combination treatment with telitacicept, cyclophosphamide and glucocorticoids for severe Granulomatous polyangiitis: a case report and literature review. | Front Immunol | 2023 | 38106422 | PubTator, text mining | PubMed |
| Systemic and targeted steroids for the treatment of IgA nephropathy. | Clin Kidney J | 2023 | 38053978 | PubTator, text mining | PubMed |
| The contribution of a proliferation-inducing ligand (APRIL) and other TNF superfamily members in pathogenesis and progression of IgA nephropathy. | Clin Kidney J | 2023 | 38053976 | PubTator, text mining | PubMed |
| Ethnicity and IgA nephropathy: worldwide differences in epidemiology, timing of diagnosis, clinical manifestations, management and prognosis. | Clin Kidney J | 2023 | 38053973 | PubTator, text mining | PubMed |
| [Humanized anti-CD25 monoclonal antibody as a salvage therapy for steroid-refractory acute graft-versus-host disease after hematopoietic stem cell transplantation]. | Zhonghua Xue Ye Xue Za Zhi | 2023 | 38049320 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8741/papers?page=6